As per DelveInsight’s assessment, the Respiratory Inhalers Market is expected to grow at an immense pace in the coming years owing to the rising air pollution which is expected to drive the demand for respiratory inhalers in the upcoming years.
DelveInsight’s “Respiratory Inhalers Market” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Respiratory Inhalers companies actively working in the market.
Respiratory Inhalers
Asthma, COPD, and other respiratory problems are becoming more common, air pollution is increasing, and there are more product development activities including product launches and regulatory clearances than ever before.
Portable medical devices known as respiratory inhalers are used to treat respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). Respiratory inhalers are used to treat and prevent flare-ups of various chronic conditions.
Respiratory Inhalers Market Insights
Geographically, the global Respiratory Inhalers market is studied in North America, Europe, Asia-Pacific, and the Rest of the World. The market for surgical energy instruments and Respiratory Inhalers is likely to be dominated by North America. Due to the rising prevalence of various respiratory disorders like chronic obstructive pulmonary disorder (COPD), asthma, and others, as well as increased exposure to smoke, dust, and chemicals, as well as various government initiatives for respiratory healthcare are expected to influence the Respiratory Inhalers market growth in the North America region.
To know more about why North America is leading the market growth in the Respiratory Inhalers market, get a snapshot of the report Respiratory Inhalers Market Trends
Recent Developments in the Respiratory Inhalers Market Report
- In October 2020, Teva Canada, a subsidiary of Teva Pharmaceutical Industries Ltd., declared the product availability of Aermony RespiClick in Canada. The inhaler is indicated for the maintenance treatment of steroid-responsive bronchial asthma as prophylactic therapy in patients 12 years of age and older and offered in a simple-to-use inhaler.
- In September 2020, Teva Respiratory, LLC., a United States affiliate of Teva Pharmaceutical Industries Ltd., announced the launch of AirDuo® Digihaler® inhalation powder and ArmonAir® Digihaler® inhalation powder, two digital maintenance inhalers for patients with asthma.
- In September 2019, Boehringer Ingelheim launched the first reusable soft mist inhaler Respimat® re-usable that can be used with up to six cartridges, reducing the carbon footprint further by 71%.
- Thus, owing to such developments in the market, rapid growth will be observed in the Respiratory Inhalers market during the forecast period
To read more about the latest highlights related to Respiratory Inhalers, get a snapshot of the key highlights entailed in the Respiratory Inhalers
Key Players in the Respiratory Inhalers Market
Some of the key market players operating in the Respiratory Inhalers market include Novartis AG, AstraZeneca, GSK plc., CHIESI Farmaceutici S.p.A, Lupin, Zydus Lifesciences Limited, Teva Pharmaceutical Industries Ltd, OMRON Corporation, Koninklijke Philips N.V., PARI GmbH, . Boehringer Ingelheim International GmbH, Glenmark Pharmaceuticals Limited, H&T Presspart Manufacturing Ltd., Rossmax International Ltd, Promed Technology Co. Limited, HELTMAN Medikal A.S., Pneuma Respiratory, Cipla Inc, Microlife Corporation, HONSUN, and others.
COVID-19 Impact Analysis on the Respiratory Inhalers Market
The Global Respiratory Inhalers market is witnessing growth due to the rising prevalence of Asthma, COPD, and other respiratory problems are becoming more common, air pollution is increasing, and there are more product development activities including product launches and regulatory clearances than ever before, are anticipated to impact the Respiratory Inhalers Market growth.
Additionally, due to lockdown restrictions, border closures, and other factors that disrupted production, supply, import, export, and other related activities of the respiratory inhalers market during the first few months, the COVID-19 pandemic had a marginally negative effect on the market growth of respiratory inhalers. Additionally, several nations around the world were compelled to shut down pulmonary function tests (PFT) facilities except in cases of emergencies due to concerns over the spread of the SARS-CoV-2 virus, which is the cause of COVID-19, and uncertainty surrounding the pandemic. However, COVID-19 hospitalization rates were higher among persons with moderate-to-severe or uncontrolled asthma.
Due to increased global knowledge and worries about lung health brought on by the COVID-19 pandemic, the market for respiratory inhalers saw growth in the second half of the year. This was mostly due to increased use of respiratory inhalers for evaluating lung function.
Scope of the Respiratory Inhalers Market Report
- Coverage: Global
- Study Period: 2019–2027
- Respiratory Inhalers Market Segmentation By Product Type: By Product Type (Dry Powder Inhalers, Metered Dosed Inhalers, Soft Mist Inhalers, Nebulizers[Mesh Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers]), and others
- Respiratory Inhalers Market Segmentation By Type: (Conventional Inhaler Devices And Smart Inhaler Devices), and others
- Respiratory Inhalers Market Segmentation By Patient Type: (Adult And Pediatric), By Indication (Asthma, COPD, Others)
- Respiratory Inhalers Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
- Key Respiratory Inhalers Companies: Novartis AG (SWX: NOVN), AstraZeneca (LON: AZN), GSK plc. (LON: GSK), CHIESI Farmaceutici S.p.A, Lupin (SE: LUPIN), Zydus Lifesciences Limited (NSE: ZYDUSLIFE), Teva Pharmaceutical Industries Ltd. (TLV: TEVA), OMRON Corporation (TYO: 6645), Koninklijke Philips N.V. (AMS: PHIA), PARI GmbH, Boehringer Ingelheim International GmbH, Glenmark Pharmaceuticals Limited (NSE: GLENMARK), H&T Presspart Manufacturing Ltd., Rossmax International Ltd, Promed Technology Co. Limited, HELTMAN Medikal A.S., Pneuma Respiratory, Cipla Inc. (NSE: CIPLA), Microlife Corporation, HONSUN, among others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
DelveInsight Analysis: The Global Respiratory Inhalers market was valued at USD 30.2 Billion in the year 2021 and is anticipated to grow with a CAGR of 4.65% during the forecasted period (2022-2027)
Which MedTech key players in the Respiratory Inhalers market are set to emerge as the trendsetter explore @ Respiratory Inhalers
Table of Contents
| 1 | Respiratory Inhalers Market Report Introduction |
| 2 | Respiratory Inhalers Market Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Respiratory Inhalers Market Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Respiratory Inhalers Market |
| 7 | Respiratory Inhalers Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Company and Product Profiles |
| 10 | Project Approach |
| 11. | About DelveInsight |
Interested in knowing how the Respiratory Inhalers market will grow by 2027? Click to get a snapshot of the Respiratory Inhalers Market Analysis
Related Reports
Endoscopy Cameras Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Endoscopy Cameras Market companies including Olympus Corporation, Stryker, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, SCHÖLLY FIBEROPTIC GMBH, among others.
Endoscopes Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Endoscopes Market companies, including Boston Scientific Corporation, CONMED Corporation, OLYMPUS CORPORATION, PENTAX Medical, among others.
Disposable Endoscopes Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Disposable Endoscopes Market companies, including Olympus Corporation, Boston Scientific Corporation, Ambu Inc., ProSurg Inc., Hill-Rom Services, Inc. (Baxter), among others.
Endoscopic Ultrasound Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Endoscopic Ultrasound Market companies, including Abbott, Olympus, Intuitive Surgical Inc, Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, among others.
Gastrointestinal Endoscopic Stricture Management Devices Market
Gastrointestinal Endoscopic Stricture Management Devices Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and Gastrointestinal Endoscopic Stricture Management Devices Market companies including Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, Abbott, Olympus, Intuitive Surgical Inc, among others.
Other Trending Reports
Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market | Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market
Latest Healthcare Blogs
- Genital Warts Treatment Market
- Vaccines Market Outlook
- Top Cardiac Devices For Heart Disease Prevention
- Burn Treatment Landscape
- Chlamydia Treatment
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Gaurav Bora
info@delveinsight.com
+1(919)321-6187